- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Celemics Inc (331920)Celemics Inc stock price live, this page displays KQ 331920 stock exchange data. View the 331920 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Celemics Inc real time stock price chart below.
What Is the Celemics Inc Stock Price Today?
The Celemics Inc stock price today is 3,130.
What Is the Stock Symbol for Celemics Inc?
The stock symbol for Celemics Inc is "331920."
What Stock Exchange Does Celemics Inc Trade On?
Celemics Inc is listed and trades on the KOSDAQ stock exchange.
Is Celemics Inc a Good Stock to Buy?
Determining whether Celemics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 331920 quote. (ISIN: KR7331920009)
What Is the Celemics Inc Stock Price Today?
The Celemics Inc stock price today is 3,130.
What Is the Stock Symbol for Celemics Inc?
The stock symbol for Celemics Inc is "331920."
What Stock Exchange Does Celemics Inc Trade On?
Celemics Inc is listed and trades on the KOSDAQ stock exchange.
Is Celemics Inc a Good Stock to Buy?
Determining whether Celemics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 331920 quote. (ISIN: KR7331920009)
KOSDAQ
Currency in KRW
3,130
-180(-5.44%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,070
3,310
52 wk Range
3,070
10,400
331920 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,0703,310
52 wk Range
3,07010,400
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
Unlock331920 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Celemics Inc Company Profile
Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development services. Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications. The company was founded in 2010 and is headquartered in Seoul, South Korea.
Compare 331920 to Peers and Sector
Metrics to compare | 331920 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship331920PeersSector | |
|---|---|---|---|---|
P/E Ratio | 1.2x | −2.6x | −0.6x | |
PEG Ratio | - | 0.01 | 0.00 | |
Price/Book | 0.7x | 1.3x | 2.6x | |
Price / LTM Sales | 4.3x | 2.9x | 3.2x | |
Upside (Analyst Target) | - | 52.8% | 44.6% | |
Fair Value Upside | Unlock | 13.5% | 7.3% | Unlock |
FAQ
What Is the Celemics (331920) Stock Price Today?
The Celemics stock price today is 3,130.00
What Stock Exchange Does Celemics Trade On?
Celemics is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Celemics?
The stock symbol for Celemics is "331920."
What Is the Celemics Market Cap?
As of today, Celemics market cap is 25.55B.
What is Celemics Earnings Per Share?
The Celemics EPS is 2,683.13.
From a Technical Analysis Perspective, Is 331920 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.